Give the gift of LIFE! Support the Population Research Institute!


Topics: health risks

Why coronavirus stats can be misleading, resulting in overblown projections

March 24, 2020 (LifeSiteNews) – Eight days ago, I wrote an article suggesting that the Chinese Coronavirus will not take hold in America the way it did in China, South Korea, and Italy. The proximate cause of my putting pen to paper (or putting fingers on keyboard, actually) was a number of alarming projections to the effect that over a million Americans may die before the epidemic here is damped down.  Such projections seemed to me then, …

Read more.

While China Lies About the Wuhan Flu, America Races for a Cure

The Chinese Coronavirus has now spread to a reported 150 countries.  But the rulers of the country where the pandemic started have good news:  They have, they declared, won a complete and total victory over the dangerous pathogen. On Thursday, Chinese propaganda outlets reported that there had been “no new infections of the novel coronavirus” in Wuhan, which is ground zero in the global pandemic.  As for China as a whole, they cited the National …

Read more.

Facebook blocks Steven Mosher’s New York Post article – Calls it “False Information.”

February 24th, Facebook blocked a post linked to Steven Mosher’s article featured in the New York Post addressing China’s role in the coronavirus epidemic. The reason? “False Information.”

Read more.

concerned woman reading pill leaflet

The Pill Kills … Again

Over the transom comes a note from my good friend, Dr. Angela Lanfranchi, who tells me that we now know five different ways that “the Pill” kills women. The first four mechanisms by which the Pill kills have been known for some time.  The Pill (1) causes blood clots resulting in heart attacks, strokes and pulmonary embolisms, (2) increases susceptibility to lethal infections of HIV and HPV, (3) increases breast, cervical and liver cancers, and …

Read more.

“Gardasil Guards Against Almost Nothing” Merck Researcher Admits

On the morning of October 2nd 2009, one of us (Joan) joined an audience of mostly health professionals and listened as Dr. Diane Harper, the leading international developer of the HPV vaccines, gave a sales pitch for Gardasil. Gardasil, as you may know, is the new vaccine that is supposed to confer protection against but strains of the sexually transmitted Human Papillomavirus (HPV). Dr. Harper came to the 4th International Public Conference on Vaccination to …

Read more.

Contraceptive Watch: The Pill

The use of “The Pill” has been linked to anywhere from a 1.5 to over 3-fold increased risk of contracting lupus, according to a new study funded in part by the Canadian Institutes of Health Research. In a study with the stated objective: “to assess whether the risk of incident systemic lupus erythematosus (SLE) is associated with the use of combined oral contraceptives (COCs),” the researchers looked at the data from the UK’s General Practice …

Read more.

Barnyard Sterilization: Part Three — The Essure Coil

A diagram of the Essure Coil in action. (Insert: The OC Register. You are looking at a so-called Essure Coil, the newest method of self-mutilation offered by the ever-inventive anti-baby types. The 1.5 inch-long device is designed to be inserted into the Fallopian tubes, where it irritates the lining and causes scar tissue to grow into and around the tiny coil. Within three months, the manufacturer promises, the Fallopian tubes will be completely impassable, …

Read more.

What You Should Know about Gardasil (HPV Vaccine)

Gardasil is a new vaccine targeting four strains of Human Papilloma Virus (HPV) generally believed to be the cause of cervical cancer. Two of these strains, HPV-16 and HPV-18 apparently account for about 70 percent of all cervical cancers. However, it is worth noting that the National Cancer Institute in the U.S. says that “direct causation has not been demonstrated.” HPV: What It Is The Human Papilloma Virus (HPV) is a sexually transmitted disease, often …

Read more.

Never miss an update!

Get our Weekly Briefing! We send out a well-researched, in-depth article on a variety of topics once a week, to large and growing English-speaking and Spanish-speaking audiences.